Viral N. Shah
Assistant Professor of Medicine & Pediatrics, Barbara Davis center for Diabetes, Adult clinic, Aurora, Colorado, USA
Viral Shah, MD is currently an Assistant Professor of Pediatrics and Medicine at Barbara Davis Center for Diabetes, University of Colorado Anschutz campus. His current area of research is to investigate the use of newer therapies and technologies for better glucose control in people with type 1 diabetes and to investigate the bone health in type 1 diabetes.
Currently, he is the local principle investigator for two projects funded by Jaeb Center for Health Research (T1D Exchange program); 1) A Randomized Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults with Type 1 Diabetes (REPLACE BG). This study is aimed to establish the safety of CGM for insulin dosing in type 1 diabetes. 2) A pilot study to assess the Efficacy and safety of Mini-dose glucagon for the treatment of non-severe hypoglycemia in adults with type 1 diabetes. This study is focused to evaluate the safety and efficacy of very small dose of stable glucagon for prevention of mild to moderate hypoglycemia. In addition, he is also Co-PI with Dr. Satish Garg on closed-loop system (artificial pancreas) studies in type 1 diabetes.
His second area of interest is to investigate bone health in people with type 1 diabetes. Better diabetes care and the availability of newer insulins and technologies such as insulin pump and CGM resulted in increased longevity in people with type 1 diabetes. With the advancing age, people with type 1 diabetes are at higher risk for bone fractures. Recently, he has published a meta-analysis of observational studies confirming three fold higher risks for major osteoporotic fractures in people with type 1 diabetes. His future research is also focused on research to understand the pathophysiology of bone fragility in type 1 diabetes.